PROCEPT BioRobotics Corp·4

Mar 9, 7:19 PM ET

Desai Antal Rohit 4

Research Summary

AI-generated summary

Updated

PROCEPT BioRobotics (PRCT) Director Antal Desai Buys Stock

What Happened
Antal Desai, a member of the board of directors of PROCEPT BioRobotics (PRCT), made multiple open-market purchases of company stock between March 5 and March 9, 2026, acquiring a total of 426,262 shares for about $10,482,942. Individual reported purchases include: 142,498 shares @ $25.44 ($3,625,021) and 24,748 shares @ $26.41 ($653,528) on 2026-03-05; 106,554 shares @ $23.33 ($2,485,713) and 53,763 shares @ $24.10 ($1,295,790) on 2026-03-06; and 43,581 shares @ $24.08 ($1,049,500), 53,818 shares @ $24.91 ($1,340,348), and 1,300 shares @ $25.42 ($33,042) on 2026-03-09. All transactions are reported as purchases (code P), which are direct acquisitions rather than option exercises or awards.

Key Details

  • Transaction dates: Mar 5, 2026; Mar 6, 2026; Mar 9, 2026. Filing date: Mar 9, 2026. Filing appears to be timely with respect to the reported dates.
  • Total shares purchased: 426,262; approximate total value: $10.48 million.
  • Per-transaction weighted-average prices and values listed above; footnotes indicate many of these are weighted averages from multiple executions within reported price ranges.
  • Footnote F2: Some shares are held by Kestrel Fund, L.P.; CPMG, Inc. (of which Mr. Desai is a shareholder/ managing partner) is general partner/manager — Mr. Desai may be deemed to share voting/investment power for the fund’s shares but disclaims beneficial ownership except for any pecuniary interest.
  • Other footnotes (F1, F3–F8): indicate the reported prices are weighted averages from multiple trades at the stated ranges; the reporting person can provide details on per-price breaks on request.
  • Shares owned after the transactions are not disclosed in the provided excerpt.

Context
These were open-market purchases (not option exercises, gifts, or awards). Purchases by directors can be read as a form of insider buying, but this summary reports facts only — it does not infer motive. Note the fund-related footnote (F2) indicates some holdings may be attributable to an investment vehicle with which the director is affiliated, rather than direct personal ownership.